CEO SUMMARY: It’s becoming a familiar story. In Houston, a pharmacogenomics lab company started strong in 2011, then payments dropped sharply when Medicare issued restrictive new guidelines for PGx testing. Next, the Medicare administrative contractor handling the claims of CompanionDx Reference Lab canceled the lab’s registry and stopped paying most Medicare claims. In the wake […]
Medicare Demands Force PGx Lab into Bankruptcy
After CMS, Medicare contractor changed policy, pharmacogenomic lab suffered big drop in revenue
- By Joseph Burns
- > From the Volume XXIV No. 5 - April 3, 2017 Issue
